OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

DAIICHI SANKYO CO. LTD/  JP3475350009  /

Frankfurt
5/30/2024  8:51:52 AM Chg. -0.9600 Volume Bid4:19:35 PM Ask4:19:35 PM Market Capitalization Dividend Y. P/E Ratio
31.5000EUR -2.96% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 61.07 bill.EUR - -
GlobeNewswire 5/22 First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination w...
GlobeNewswire 5/16 JD.com Announces First Quarter 2024 Results
GlobeNewswire 5/7 Esperion Reports First Quarter 2024 Financial Results
GlobeNewswire 5/2 Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 5/1 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 4/29 Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Eva...
GlobeNewswire 3/29 Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
GlobeNewswire 3/22 CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose ...
GlobeNewswire 2/27 Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 2/15 Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 1/3 Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including...
GlobeNewswire 11/29/2023 INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breas...
GlobeNewswire 11/28/2023 Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
GlobeNewswire 11/7/2023 Esperion Reports Third Quarter 2023 Financial Results
GlobeNewswire 11/2/2023 Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update
GlobeNewswire 11/2/2023 vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer
TeleTrader 10/20/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs
GlobeNewswire 10/2/2023 Prevent Cancer Foundation raises more than $2 million for cancer prevention and early detection at a...
GlobeNewswire 9/27/2023 CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal includ...
GlobeNewswire 9/13/2023 Myricx Expands its Leadership Team with the Appointment of Dr. Robert McLeod as VP Clinical Developm...
GlobeNewswire 9/6/2023 Jordanian royalty to grace Prevent Cancer Foundation 29th Annual Gala
GlobeNewswire 8/31/2023 RAIN Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in...
GlobeNewswire 3/24/2022 Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform
GlobeNewswire 3/7/2022 Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
GlobeNewswire 3/3/2022 AIM ImmunoTech Appoints Robert Dickey, IV as Chief Financial Officer